Meta Analysis of the Efficacy of Non-pharmaceutical Chinese Medicine Therapy in the Treatment of Obese Polycystic Ovary Syndrome
Abstract
Objective: To systematically evaluate the effects of acupuncture, auricular point sticking, acupoint catgut embedding, cupping and other non-pharmaceutical Chinese medicine therapies on sex hormone as well as glucose and lipid metabolism in patients with obese polycystic ovary syndrome. Method: The databases such as China National Knowledge Infrastructure were searched by computer to collect the literature on the treatment of obese polycystic by non-pharmaceutical Chinese medicine therapy combined with western medicine or lifestyle change, and the literature quality of the included literature was evaluated, and finally the data were analyzed. A total of 15 randomized controlled trial (RCT) literature were included in this study, with a total of 1263 patients. Results: Non-pharmaceutical Chinese medicine therapy combined with metformin or lifestyle can reduce body mass index, insulin resistance index, fasting plasma insulin, fasting blood glucose, luteinizing hormone, ratio of luteinizing hormone to follicle stimulating hormone, testosterone, but it has no obvious advantage over follicle stimulating hormone (FSH). Conclusion: Compared with simple application of metformin or lifestyle change, traditional Chinese medicine non drug therapy combined with metformin or lifestyle change can better improve sex hormone and blood glucose metabolism in obese PCOS patients.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 1,263 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.